Breedt LC, Pontillo G, Santos FAN, Vriend C, Prados F, Wink AM, Bisecco A, Cagol A, Calabrese M, Castellaro M, Collorone S, Cortese R, De Stefano N, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Høgestøl EA, Llufriu S, Martinez-Heras E, Solana E, Messina S, Moccia M, Nygaard GO, Palace J, Pinter D, Rocca MA et al. (2026)
Structure-function multilayer network integration and cognition in multiple sclerosis
Netw Neurosci, 10 (2), 400-417
DOI 10.1162/NETN.a.545, PubMed 42039096

Høgestøl EA, Brustad ÅW, Celius EG, Meling M, Berg-Hansen P, Kro GB, König M, Schanke Y, Halvorsen B, Warren DJ, Gehin JE, Bolstad N, Nygaard GO (2026)
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab
BMJ Neurol Open, 8 (1), e001477
DOI 10.1136/bmjno-2025-001477, PubMed 41877736

Korbmacher M, Lie IA, Wesnes K, Westman E, Espeseth T, Andreassen OA, Harbo H, Nygaard GO, Westlye LT, Wergeland S, Myhr KM, Høgestøl EA, Torkildsen Ø (2026)
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing
Neuroimage, 338, 122118
DOI 10.1016/j.neuroimage.2026.122118, PubMed 42419658